Benefit and cost of repeating a severe acute respiratory coronavirus virus 2 (SARS-CoV-2) polymerase chain reaction (PCR) test after the second day of hospitalization in five hospitals during various community prevalences and vaccination rates

Authors:

Abstract
Universal SARS-CoV-2 PCR was performed upon admission and again after two inpatient days. As community-wide prevalence, admission, and vaccination rates varied, number-needed-to-benefit (NNB) and cost-per-additional-detection (Cd) fluctuated between 16-769 and 29,400 respectively, and negatively associated with new hospital admissions. No other community indicator associated with NNB and Cd.